Home Table of Contents

§ 10231.1903. Medical marijuana research program administration

Purdon's Pennsylvania Statutes and Consolidated StatutesTitle 35 P.S. Health and SafetyEffective: May 17, 2016

Purdon's Pennsylvania Statutes and Consolidated Statutes
Title 35 P.S. Health and Safety (Refs & Annos)
Chapter 64. Medical Marijuana Act (Refs & Annos)
Chapter 19. Research Program (Refs & Annos)
Effective: May 17, 2016
35 P.S. § 10231.1903
§ 10231.1903. Medical marijuana research program administration
Currentness
(a) General rule.--The department shall establish a research study for each serious medical condition. The department shall engage universities within this Commonwealth to participate in the collection, collation, analysis and conclusive findings of the research studies. The department shall, by regulation, establish the procedure to be used by health care medical marijuana organizations with respect to:
(1) Real time inventory tracking.
(2) Real time tracking of the medical marijuana dispensed.
(3) Recall of defective medical marijuana.
(b) Request for distributions.--The department shall establish a form and procedure for universities selected to participate in a research study to request distributions from the fund to conduct research on medical marijuana, including administrative costs. These distributions shall also be used to pay for the cost of the medical marijuana so that it is not borne by the patient participating in the research study. The forms shall include, at a minimum, the following:
(1) The form or forms of medical marijuana to be studied.
(2) The serious medical condition to be studied.
(c) Research reports.--
(1) A vertically integrated health system shall report on the effectiveness of the use of medical marijuana for the treatment of the serious medical condition studied and all counterindications and noted side effects.
(2) The department shall notify the vertically integrated health system and the university participating in the research study of the data which is required to meet the United States Food and Drug Administration's and the United States Drug Enforcement Administration's approval for the research study.
(3) The first report, including the data required under paragraph (2), shall be submitted to the department and made publicly available within 180 days of the initiation of a research study for a specific serious medical condition.
(4) An annual report of the data required under paragraph (2) shall be submitted to the department beginning one year after the initiation of a research study for a specific serious medical condition and each year thereafter.

Credits

2016, April 17, P.L. 84, No. 16, § 1903, effective in 30 days [May 17, 2016].
35 P.S. § 10231.1903, PA ST 35 P.S. § 10231.1903
Current through Act 10 of the 2024 Regular Session. Some statute sections may be more current, see credits for details.
End of Document